Class information for:
Level 1: O GLYCOSYLATION//PPGALNAC T//GALNAC TRANSFERASE

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
22552 377 42.5 87%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
103 3       O GLCNACYLATION//O GLCNAC TRANSFERASE//O GLCNACASE 73436
321 2             N GLYCAN//GLYCOBIOLOGY//GLYCOPROTEOMICS 18230
22552 1                   O GLYCOSYLATION//PPGALNAC T//GALNAC TRANSFERASE 377

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 O GLYCOSYLATION authKW 944975 20% 15% 76
2 PPGALNAC T authKW 816697 3% 92% 11
3 GALNAC TRANSFERASE authKW 728942 4% 60% 15
4 DEV GLYCOBIOL UNIT address 539959 3% 67% 10
5 N ACETYLGALACTOSAMINYLTRANSFERASE authKW 530137 3% 55% 12
6 GALNAC T3 authKW 496092 2% 88% 7
7 UDP GALNAC POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE authKW 496092 2% 88% 7
8 GALNT authKW 440969 2% 78% 7
9 POLYPEPTIDE GALNAC TRANSFERASE authKW 404974 1% 100% 5
10 POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE authKW 404974 1% 100% 5

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 Biochemistry & Molecular Biology 2462 66% 0% 247
2 Oncology 331 17% 0% 64
3 Cell Biology 230 14% 0% 54
4 Biophysics 150 8% 0% 31
5 Biochemical Research Methods 65 5% 0% 20
6 Developmental Biology 20 2% 0% 7
7 Virology 4 1% 0% 5
8 Biotechnology & Applied Microbiology 2 3% 0% 10
9 Parasitiology 2 1% 0% 3
10 Pathology 2 1% 0% 5

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 DEV GLYCOBIOL UNIT 539959 3% 67% 10
2 COPENHAGEN GLYC 317787 5% 21% 19
3 WA BERNBAUM CYST FIBROSIS 287973 2% 44% 8
4 DEV GLYCOBIOL SECT 259182 1% 80% 4
5 SECT BIOL CHEM 228164 5% 16% 18
6 GLYCOGENE FUNCT TEAM 105776 2% 16% 8
7 ABT MOL ENTWICKLUNGSGENET 80995 0% 100% 1
8 CANC UK BREAST CANC BIOL 80995 0% 100% 1
9 CHEM BIOCHEM PEDIAT 80995 0% 100% 1
10 COMP SCI CUI 80995 0% 100% 1

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 GLYCOBIOLOGY 31069 9% 1% 33
2 GLYCOCONJUGATE JOURNAL 14865 5% 1% 19
3 JOURNAL OF BIOLOGICAL CHEMISTRY 2587 19% 0% 70
4 TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY 1284 1% 1% 3
5 ONCOTARGET 645 3% 0% 10
6 NEOPLASIA 427 1% 0% 3
7 PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS 364 1% 0% 4
8 HYBRIDOMA 342 1% 0% 3
9 PATHOBIOLOGY 293 1% 0% 2
10 CHEMISTRY & BIOLOGY 268 1% 0% 3

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 O GLYCOSYLATION 944975 20% 15% 76 Search O+GLYCOSYLATION Search O+GLYCOSYLATION
2 PPGALNAC T 816697 3% 92% 11 Search PPGALNAC+T Search PPGALNAC+T
3 GALNAC TRANSFERASE 728942 4% 60% 15 Search GALNAC+TRANSFERASE Search GALNAC+TRANSFERASE
4 N ACETYLGALACTOSAMINYLTRANSFERASE 530137 3% 55% 12 Search N+ACETYLGALACTOSAMINYLTRANSFERASE Search N+ACETYLGALACTOSAMINYLTRANSFERASE
5 GALNAC T3 496092 2% 88% 7 Search GALNAC+T3 Search GALNAC+T3
6 UDP GALNAC POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE 496092 2% 88% 7 Search UDP+GALNAC+POLYPEPTIDE+N+ACETYLGALACTOSAMINYLTRANSFERASE Search UDP+GALNAC+POLYPEPTIDE+N+ACETYLGALACTOSAMINYLTRANSFERASE
7 GALNT 440969 2% 78% 7 Search GALNT Search GALNT
8 POLYPEPTIDE GALNAC TRANSFERASE 404974 1% 100% 5 Search POLYPEPTIDE+GALNAC+TRANSFERASE Search POLYPEPTIDE+GALNAC+TRANSFERASE
9 POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE 404974 1% 100% 5 Search POLYPEPTIDE+N+ACETYLGALACTOSAMINYLTRANSFERASE Search POLYPEPTIDE+N+ACETYLGALACTOSAMINYLTRANSFERASE
10 GALNAC T6 242985 1% 100% 3 Search GALNAC+T6 Search GALNAC+T6

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref.
in cl.
Shr. of ref. in
cl.
Citations
1 BENNETT, EP , MANDEL, U , CLAUSEN, H , GERKEN, TA , FRITZ, TA , TABAK, LA , (2012) CONTROL OF MUCIN-TYPE O-GLYCOSYLATION: A CLASSIFICATION OF THE POLYPEPTIDE GALNAC-TRANSFERASE GENE FAMILY.GLYCOBIOLOGY. VOL. 22. ISSUE 6. P. 736-756 80 50% 120
2 KONG, Y , JOSHI, HJ , SCHJOLDAGER, KTBG , MADSEN, TD , GERKEN, TA , VESTER-CHRISTENSEN, MB , WANDALL, HH , BENNETT, EP , LEVERY, SB , VAKHRUSHEV, SY , ET AL (2015) PROBING POLYPEPTIDE GALNAC-TRANSFERASE ISOFORM SUBSTRATE SPECIFICITIES BY IN VITRO ANALYSIS.GLYCOBIOLOGY. VOL. 25. ISSUE 1. P. 55 -65 46 84% 13
3 REVOREDO, L , WANG, SJ , BENNETT, EP , CLAUSEN, H , MOREMEN, KW , JARVIS, DL , TEN HAGEN, KG , TABAK, LA , GERKEN, TA , (2016) MUCIN-TYPE O-GLYCOSYLATION IS CONTROLLED BY SHORT- AND LONG-RANGE GLYCOPEPTIDE SUBSTRATE RECOGNITION THAT VARIES AMONG MEMBERS OF THE POLYPEPTIDE GALNAC TRANSFERASE FAMILY.GLYCOBIOLOGY. VOL. 26. ISSUE 4. P. 360 -376 47 78% 1
4 TEN HAGEN, KG , FRITZ, TA , TABAK, LA , (2003) ALL IN THE FAMILY: THE UDP-GALNAC : POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASES.GLYCOBIOLOGY. VOL. 13. ISSUE 1. P. 1R-16R 79 55% 180
5 GERKEN, TA , REVOREDO, L , THOME, JJC , TABAK, LA , VESTER-CHRISTENSEN, MB , CLAUSEN, H , GAHLAY, GK , JARVIS, DL , JOHNSON, RW , MONIZ, HA , ET AL (2013) FAMILY OF GLYCOSYLTRANSFERASES (PPGALNAC TS) ACTS AS A SWITCH DIRECTING GLYCOPEPTIDE SUBSTRATE GLYCOSYLATION IN AN N- OR C-TERMINAL DIRECTION, FURTHER CONTROLLING MUCIN TYPE O-GLYCOSYLATION.JOURNAL OF BIOLOGICAL CHEMISTRY. VOL. 288. ISSUE 27. P. 19900-19914 47 65% 14
6 HANG, HC , BERTOZZI, CR , (2005) THE CHEMISTRY AND BIOLOGY OF MUCIN-TYPE O-LINKED GLYCOSYLATION.BIOORGANIC & MEDICINAL CHEMISTRY. VOL. 13. ISSUE 17. P. 5021 -5034 78 42% 140
7 GERKEN, TA , RAMAN, J , FRITZ, TA , JAMISON, O , (2006) IDENTIFICATION OF COMMON AND UNIQUE PEPTIDE SUBSTRATE PREFERENCES FOR THE UDP-GALNAC: POLYPEPTIDE ALPHA-N-ACETYLGALACTOSAMINYLTRANSFERASES T1 AND T2 DERIVED FROM ORIENTED RANDOM PEPTIDE SUBSTRATES.JOURNAL OF BIOLOGICAL CHEMISTRY. VOL. 281. ISSUE 43. P. 32403-32416 41 85% 30
8 KATO, K , TAKEUCHI, H , KANOH, A , MIYAHARA, N , NEMOTO-SASAKI, Y , MORIMOTO-TOMITA, M , MATSUBARA, A , OHASHI, Y , WAKI, M , USAMI, K , ET AL (2010) LOSS OF UDP-GALNAC:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3 AND REDUCED O-GLYCOSYLATION IN COLON CARCINOMA CELLS SELECTED FOR HEPATIC METASTASIS.GLYCOCONJUGATE JOURNAL. VOL. 27. ISSUE 2. P. 267 -276 36 88% 12
9 GERKEN, TA , TEN HAGEN, KG , JAMISON, O , (2008) CONSERVATION OF PEPTIDE ACCEPTOR PREFERENCES BETWEEN DROSOPHILA AND MAMMALIAN POLYPEPTIDE-GALNAC TRANSFERASE ORTHOLOG PAIRS.GLYCOBIOLOGY. VOL. 18. ISSUE 11. P. 861-870 38 83% 14
10 GERKEN, TA , JAMISON, O , PERRINE, CL , COLLETTE, JC , MOINOVA, H , RAVI, L , MARKOWITZ, SD , SHEN, W , PATEL, H , TABAK, LA , (2011) EMERGING PARADIGMS FOR THE INITIATION OF MUCIN-TYPE PROTEIN O-GLYCOSYLATION BY THE POLYPEPTIDE GALNAC TRANSFERASE FAMILY OF GLYCOSYLTRANSFERASES.JOURNAL OF BIOLOGICAL CHEMISTRY. VOL. 286. ISSUE 16. P. 14493 -14507 43 60% 46

Classes with closest relation at Level 1



Rank Class id link
1 3652 SIALYL TN//CARBOHYDRATE ANTIGEN//TN ANTIGEN
2 32832 HELIX POMATIA AGGLUTININ//HELIX POMATIA LECTIN//HELIX POMATIA LECTIN HPA
3 17746 CD43//LEUKOSIALIN//SIALOPHORIN
4 23110 INSECT CELLS//FUSED LOBES//INSECT CELL GLYCOSYLATION
5 1584 MUC1//MUC4//MUCIN
6 14110 STRUCT GLYCOBIOL SECT//ABO GENOTYPING//ABO GENE
7 2218 GLYCOPROTEOMICS//GLYCOMICS//LECTIN MICROARRAY
8 16451 BETA 1 4 GALACTOSYLTRANSFERASE I//GALACTOSYLTRANSFERASE//BETA 1 4 GALACTOSYLTRANSFERASE
9 37128 C MANNOSYLATION//MESIR PASTE//ACONOGONON MOLLE
10 10684 GLYCOPEPTIDES//TUMOR VACCINOL//ANTITUMOR VACCINES

Go to start page